Oberland Biotech develops biotechnology-driven food and nutritional products, focusing on cultivated proteins and functional ingredients.
Oberland Biotech has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Oberland Biotech's investors include 999 Family Office.
Oberland Biotech is headquartered in Zug, Switzerland.
Oberland Biotech develops biotechnology-driven food and nutritional products, focusing on cultivated proteins and functional ingredients.
Oberland Biotech is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oberland Biotech — Funding & Investors." VCBacked, May 1, 2026, https://www.vcbacked.co/company/oberland-biotech. Accessed July 25, 2026.
VCBacked. (2026). Oberland Biotech — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/oberland-biotech
{{cite web |title=Oberland Biotech — Funding & Investors |url=https://www.vcbacked.co/company/oberland-biotech |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated